OVERVIEW

Why Glial Cells Hurt: Talking to Patients About Chronic Pain is organized by College of Psychiatric and Neurologic Pharmacists (CPNP) and will be held from Jun 01, 2018 - Apr 25, 2021. This Course has been approved for a maximum of 1.0 Contact Hours.

Target Audience:
This course is designed for pharmacists and/or other healthcare professionals involved in the medication management of individuals living with psychiatric, neurologic and/or substance use disorders.

Session Summary:
Despite the widespread use of opioids, the incidence of chronic pain has not decreased in the U.S. in the past 20 years. Pharmacists must understand the pathophysiology of chronic pain and educate both patients and providers on appropriate multimodal therapies. This presentation will explore the relationship between pathophysiology and pharmacology in chronic pain and provide plain language strategies to educate patients and providers.

Course Requirements:
You will proceed through the following steps to satisfactorily complete this course:
• Review the full content of the activity and reflect upon its teachings.
• Complete the post-test at the end of the activity no later than the closing activity date. (login first)
• Complete the evaluation at the end of the activity. (login first)
• If necessary, complete the post-test retest no later than the closing activity date. (login first)
• Receive a passing grade (70%).
• Provide the necessary details in your profile to ensure correct reporting by CPNP to CPE Monitor. (login first)

Learning Objectives:
• Identify the common types of chronic musculoskeletal pain and describe the proposed pathophysiology of these disorders.
• Explain the role of glial cells in the mediation of pain, and glial cell activation in response to opioids.
• Apply the principles of pain physiology education in communicating central sensitization and its role in chronic pain with patients.

Additional details will be posted as soon as they are available.